Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy
Prodrugs are chemically modified drug molecules that are inactive before administration. After administration, they are converted in situ to parent drugs and induce the mechanism of action. The development of prodrugs has upgraded conventional drug treatments in terms of bioavailability, targeting,...
Saved in:
Main Authors: | Ding, Chendi, Chen, Chunbo, Zeng, Xiaowei, Chen, Hongzhong, Zhao, Yanli |
---|---|
Other Authors: | School of Chemistry, Chemical Engineering and Biotechnology |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/165552 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Protein-based artificial nanosystems in cancer therapy
by: Zhang, Nan, et al.
Published: (2021) -
Copper-based hybrid nanosystems for external stimuli mediated cancer therapy
by: Jana, Deblin
Published: (2021) -
NIR-light-activated combination therapy with a precise ratio of photosensitizer and prodrug using a host-guest strategy
by: Chen, Hongzhong, et al.
Published: (2020) -
Light-responsive prodrug-based supramolecular nanosystems for site-specific combination therapy of cancer
by: Phua, Fiona Soo Zeng, et al.
Published: (2020) -
NIR-light-intensified hypoxic microenvironment for cascaded supra-prodrug activation and synergistic chemo/photodynamic cancer therapy
by: Chen, Hongzhong, et al.
Published: (2022)